Savient Pharmaceuticals, Inc.
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
Other Names/Subsidiaries
- Bio-Technology General Corporation
Latest on Savient Pharmaceuticals, Inc.
At 11:15 am on Aug. 17, the Health Resources & Services Administration released an advanced copy of a Federal Register notice proposing another delay in its final rule on calculating 340B drug price
AstraZeneca PLC subsidiary Ardea Biosciences Inc. 's gout therapy Zurampic (lesinurad) challenged FDA's regulatory flexibility when secondary clinical endpoints failed to provide the expected b
The FDA's Arthritis Advisory Committee (AAC) on Oct. 23 in a 10-4 vote recommended approval of lesinurad, an experimental drug from AstraZeneca plc and its US unit Ardea Biosciences Inc., as a treatme
Basilea Pharmaceutica, which develops products in the therapeutic areas of bacterial infections, fungal infections and oncology, has named David Veitch chief commercial officer – effective 1 September